UNE POLITIQUE D’INNOVATION ORIGINALE
Les Mérieux « Research Grants »
Ces contrats de recherche ont pour objectif de susciter et identifier des projets innovants. Ils financent des investigateurs (juniors ou seniors, médecins ou scientifiques) pour des projets réalisés dans des laboratoires privés ou publics, dans le domaine des maladies infectieuses, des cancers et maladies cardiovasculaires, de la sécurité alimentaire, de la nutrition et de l’eau.
Au terme d’une sélection rigoureuse, les investigateurs retenus, reçoivent un financement sur 2 ans ( jusqu’à 300 000 € ), l’Institut Mérieux se réservant la possibilité de nouer des partenariats stratégiques en cas de succès.
Deux types de contrats coexistent :- les « Advanced Research Grants » pour les projets les plus innovants présentant des enjeux stratégiques importants
- les « Starting Research Grants » pour des projets intéressants mais devant clairement montrer leur faisabilité.
Projets sélectionnés
Mérieux Research Grants 2010
Emile BEAULIEU
nserm – Collège de France Paris
- Novel approach of the prevention/treatment of naturopathies with dementia, including Alzheimer's diseases - Emergency of FKBP52 immunophilin function an Tay pathophysiology
Francis CHISARI
Scripps – La Jolla
- Induction of the interferon response by the Hepatitis C Virus
Daniel KALMAN
Emory University - Atlanta
- Development of novel therapeutics for treating MTB infection
Anne O’GARRA
National Institute for Medical Research
- Transcriptional signatures in human tuberculosis
Kavli Nanoscience Institute
- Mass spectrometry based on NEMS arrays (NEMS-MS)
Philippe SANSONETTI
Institut Pasteur Paris
- Deciphering the regulation of innate antimicrobial peptides to develop innovative anti-infectious drugs
Hong-Bin SHU
University Wuhan
- Molecular mechanisms of cellular antiviral response
Luc TEYTON
Scripps – La Jolla
- Development of a new immunomodulators using High Troughtup sreening
Zhouping WANG
Jiangnan University - Wuxi
- Aptamer recognition and nanostructure sensing based on ultrasensitive bioanalysis for food nutrition and food safety
Bob WEINBERG
Whitehead Institute for Biomedical Research - Cambridge
- Factors Regulating the Stem Cell State of Normal and Neoplastic Cells
Chen Yu ZHANG
School of life Sciences Nanjing University
- Milk MicroRNA expression profile as a novel biomarker for raw milk quality detection
Mérieux Research Grants 2009
Francis ALBARDE
ENS (Ecole Normale Supérieure) in Lyon -France
- the natural isotopic variability of metals associated with some cancer pathologies
Fudan University Cancer Hospital in Shanghai - China
- Seeking the Novel Biomarkers in Colorectal microRNAome
Lee-Ann JAYKUS
Food Science Department North Carolina State University in Raleigh - USA
- Development and application of novel approaches for human enteric virus concentration and purification from complex sample in support of rapid molecular-based detection
Jan KARLSEDER
Salk Institute for Biological Studies, in La Jolla, California - USA
- C. elegans as a model for telmomere Length Regulation in cancer
Pierre MIOSSEC
Hospices Civils de Lyon - France
- IL-17 and Th17 cells in rheumatoid arthritis
Germain PUZO
CNRS (Centre National de la Recherche Scientifique) et University Paul Sabatier in Toulouse - France
- Sulfoglycolipid antigens as subunit candidate TB vaccine
Philippe ROINGEARD
University François Rabelais in Tours - France
- New fusion proteins and their application for preparation of hepatitis C vaccines
Ajit VARKI
University of California, San Diego - USA
- Roles of a Non-human Sialic Acid in Cancer, Cardiovascular Diseases and Food and Drug Safety
Inder VERMA
Salk Institute for Biological Studies, in La Jolla, California - USA
- Glioblastoma : The rôle of NF kB and its potential as therapeutictarget
Zhiwei WU
Nanjing University in Nanjing - China
- Design of an innate immune agent as an HIV-1 entry inhibitor
Rong ZHOU
Guangzhou Institute of Respiratory Diseases in Guangzhou - China
- Study on trivalent vaccine against human adenovirus and a “virus display” platform for vaccine development